Sibutramine-Induced Nonischemic Cardiomyopathy.
Shah MS, Patel ZK, Bharucha R, Talati T, Benz M.
Cureus. 2022 Jan 26;14(1):e21650. doi: 10.7759/cureus.21650. eCollection 2022 Jan.
Integration of implantable device therapy in patients with heart failure. A clinical consensus statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC).
Mullens W, Dauw J, Gustafsson F, Mebazaa A, Steffel J, Witte KK, Delgado V, Linde C, Vernooy K, Anker SD, Chioncel O, Milicic D, Hasenfuß G, Ponikowski P, von Bardeleben RS, Koehler F, Ruschitzka F, Damman K, Schwammenthal E, Testani JM, Zannad F, Böhm M, Cowie MR, Dickstein K, Jaarsma T, Filippatos G, Volterrani M, Thum T, Adamopoulos S, Cohen-Solal A, Moura B, Rakisheva A, Ristic A, Bayes-Genis A, Van Linthout S, Tocchetti CG, Savarese G, Skouri H, Adamo M, Amir O, Yilmaz MB, Simpson M, Tokmakova M, González A, Piepoli M, Seferovic P, Metra M, Coats AJS, Rosano GMC.
Eur J Heart Fail. 2024 Feb;26(2):483-501. doi: 10.1002/ejhf.3150. Epub 2024 Jan 25.
Phrenic paralysis during cardiac electronic device implantation: incidence, causes and clinical course.
López-Gil M, Fontenla A, Juliá J, Parra JJ, Arribas F.
Europace. 2016 Oct;18(10):1561-1564. doi: 10.1093/europace/euv423. Epub 2016 Jan 29.
Cephalic vs. subclavian lead implantation in cardiac implantable electronic devices: a systematic review and meta-analysis.
Benz AP, Vamos M, Erath JW, Hohnloser SH.
Europace. 2019 Jan 1;21(1):121-129. doi: 10.1093/europace/euy165.
Cardiac implantable electronic device and vascular access: Strategies to overcome problems.
Kusztal M, Nowak K.
J Vasc Access. 2018 Nov;19(6):521-527. doi: 10.1177/1129729818762981. Epub 2018 Mar 19.
Simplified cardiac resynchronization implantation technique involving right access and a triple-guide/single introducer approach.
Romeyer-Bouchard C, Da Costa A, Abdellaoui L, Messier M, Thévenin J, Afif Z, Samuel B, Kihel A, Cerisier A, Convert G, Isaaz K.
Heart Rhythm. 2005 Jul;2(7):714-9. doi: 10.1016/j.hrthm.2005.04.005.
Fluoroscopy-guided axillary vein access vs cephalic vein access in pacemaker and defibrillator implantation: Randomized clinical trial of efficacy and safety.
Jiménez-Díaz J, Higuera-Sobrino F, Piqueras-Flores J, Pérez-Díaz P, González-Marín MA.
J Cardiovasc Electrophysiol. 2019 Sep;30(9):1588-1593. doi: 10.1111/jce.14060. Epub 2019 Jul 23.
Characteristics of Patients with Spontaneous Coronary Artery Dissection Presenting with Sudden Cardiac Arrest in the United States and the Potential Role of Implantable Cardioverter Defibrillator Therapy.
Krittanawong C, Qadeer YK, Ang SP, Wang Z, Alam M, Sharma S, Jneid H.
Rev Cardiovasc Med. 2024 Sep 9;25(9):318. doi: 10.31083/j.rcm2509318. eCollection 2024 Sep.
Venous System Interventions for Device Implantation.
Marcial JM, Worley SJ.
Card Electrophysiol Clin. 2018 Mar;10(1):163-177. doi: 10.1016/j.ccep.2017.11.017.
Body mass index is related to unsuccessful puncture attempts and failure to axillary vein cannulation during ultrasound-guided cardiac electronic device implantation.
De Sensi F, Addonisio L, Baratta P, Breschi M, Cresti A, Miracapillo G, Limbruno U.
J Interv Card Electrophysiol. 2021 Aug;61(2):253-259. doi: 10.1007/s10840-020-00800-3. Epub 2020 Jun 23.
